Search

everythinglearnresearchcommunity

for

Search:↓

A new compound shows promise as a topical treatment for hair loss.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Better diagnosis and control of thallium poisoning are needed to prevent severe outcomes.

Emulgels are promising for delivering drugs topically due to their easy spreadability and stability.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Methionine intake changes tooth germ development in newborn rats.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

New technologies improve diagnosis and treatment of digestive disorders.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Switching to generic tacrolimus was safe, effective, and saved money.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

The new gel improves skin delivery of a drug, potentially reducing dose frequency and side effects.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.